Cover Image
Market Research Report

Empty Capsules Market - Growth, Trends, and Forecast (2020 - 2025)

Published by Mordor Intelligence LLP Product code 925237
Published Content info 120 Pages
Delivery time: 2-3 business days
Price
Back to Top
Empty Capsules Market - Growth, Trends, and Forecast (2020 - 2025)
Published: February 1, 2020 Content info: 120 Pages
Description

Empty capsules are stable shells that contain encapsulate medicines, which are administered in a variety of dosage forms. Empty capsules are of two types in the market namely, gelatin capsules and non-gelatin capsules. Of these, the vegetable/non-gelatin capsules are expected to witness considerable demand in the coming years. This is attributed to the preference for the same among the consumers due to its natural or non-animal origin.

The key factors that boost the growth of the global empty capsules market include growth in popularity of capsules over other drug delivery forms and an increase in strategic collaborations between empty capsule suppliers and gelatin manufacturers. In addition, rapid advancements in capsule delivery technologies are set to supplement the market growth. However, ethical concerns, price fluctuations regarding gelatin material, and stringent regulations in the pharmaceutical industry are expected to hamper the market growth.

Key Market Trends

Cardiovascular Therapy Drugs is Expected to Witness a Healthy CAGR

Cardiovascular diseases (CVD) are highly prevalent globally. According to the American Heart Association 2018 data, cardiovascular disease is the leading global cause of death, accounting for more than 17.9 million deaths per year in 2015, a number that is expected to grow to more than 23.6 million by 2030.

Empty capsules are useful in masking the taste of cardiac therapy drugs. This prevents the patient from feeling nauseated. Hence as prevalence of CVDs increase, the demand for cardiac therapy drugs will also increase. This factor will positively impact the empty capsules market.

North America is Expected to Dominate the Market

The large share of this region is due to the rising preference for capsule-based nutraceutical formulations. Since these nutraceuticals help in the prevention of major health problems, such as obesity, cancer, and arthritis, there has been an increase in the consumption of these nutraceuticals. Since capsules are the most preferred solid oral dosage forms, the demand for empty capsules in the nutraceutical industry is high in this region.

About 71% of US adults or more than 170 million Americans have been reported as taking dietary supplements, according to the most recent annual survey conducted by Ipsos Public Affairs on behalf of the Council for Responsible Nutrition (CRN). The 2016 CRN Consumer Survey on Dietary Supplements found that the five most popular supplements are the multivitamin (taken by 75% of supplement users), vitamin D (37%), vitamin C (34%), calcium (29%), and vitamin B/B complex (24%).

Moreover, the North American countries of the United States (US) and Canada have a developed and well-structured health care system. These systems also encourage research and development. These policies encourage global players to enter the US and Canada. As a result, these countries enjoy the presence of many global market players. As high demand is met by the presence of global players in the region, the market is further expected to increase.

Competitive Landscape

Majority of the empty capsules are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market. Moreover, Asia-pacific is witnessing an emergence of some small players due to the rise of awareness. This has also helped the market grow.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support
Table of Contents
Product Code: 64988

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Pharmaceutical Applications
    • 4.2.2 Technological Advancements in Empty Capsules
    • 4.2.3 Growing Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 Rising Gelatin Prices and Lower Availability of Raw Materials
    • 4.3.2 Cultural Practices and Dietary Restrictions
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Gelatin Capsules
    • 5.1.2 Non-gelatin Capsules
  • 5.2 By Therapeutic Application
    • 5.2.1 Antibiotic and Antibacterial Drugs
    • 5.2.2 Vitamins and Dietary Supplements
    • 5.2.3 Antacid and Antiflatulent Preparations
    • 5.2.4 Cardiovascular Therapy Drugs
    • 5.2.5 Other Therapeutic Applications
  • 5.3 By End User
    • 5.3.1 Pharmaceutical Industry
    • 5.3.2 Nutraceutical Industry
    • 5.3.3 Cosmetics Industry
    • 5.3.4 Research Laboratories
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 ACG Worldwide
    • 6.1.2 Bright Pharma Caps Inc.
    • 6.1.3 Capscanada Corporation
    • 6.1.4 Lonza
    • 6.1.5 Medi-Caps Ltd
    • 6.1.6 Qualicaps
    • 6.1.7 Roxlor LLC
    • 6.1.8 Snail Pharma Industry Co. Ltd
    • 6.1.9 Sunil Healthcare Limited
    • 6.1.10 Suheung Co. Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Back to Top